|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.739
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.711
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.579
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.579
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.508
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.386
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.371
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.346
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.310
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.298
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.242
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.230
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.226
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.217
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.195
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.187
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.178
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.168
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.160
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.154
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.142
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.137
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.133
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.120
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.112
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.107
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.107
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.106
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.105
|
|
|
|
negative regulation of nf kappab transcription factor activity
|
GO:0032088 |
15 |
0.092
|
|
|
|
positive regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032436 |
23 |
0.082
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.080
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.077
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.075
|
|
|
|
regulation of transcription from rna polymerase ii promoter by galactose
|
GO:0000431 |
1 |
0.072
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.070
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.069
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.069
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.069
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.064
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.061
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.061
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.060
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.060
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.059
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to dna damage
|
GO:1902229 |
14 |
0.059
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.059
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.059
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.059
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.059
|
Mouse |
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.058
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
34 |
0.057
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.056
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.056
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.056
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.056
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.055
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.055
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.055
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.054
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.052
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.051
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.050
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.048
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.048
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.047
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.047
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.047
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.047
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
30 |
0.047
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.046
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.045
|
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.045
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.045
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.044
|
|
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
25 |
0.044
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.044
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.043
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.042
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.042
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.040
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.040
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.039
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.039
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.039
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.039
|
Mouse |
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.038
|
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
31 |
0.038
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.037
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.037
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.037
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.037
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.037
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.036
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.035
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.035
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.035
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.035
|
|
|
|
positive regulation of transcription by galactose
|
GO:0000411 |
1 |
0.034
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.034
|
|
|
|
regulation of protein sumoylation
|
GO:0033233 |
4 |
0.033
|
|
|
|
regulation of clathrin mediated endocytosis
|
GO:2000369 |
4 |
0.033
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.033
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.033
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.033
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.033
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.032
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.032
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.032
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.032
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.031
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.031
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.031
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.031
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.030
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.030
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.030
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.030
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.030
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.029
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.029
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.029
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.029
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.029
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.029
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.029
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.029
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.029
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.028
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.028
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.028
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.028
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.028
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.028
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.027
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.027
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.027
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.027
|
|
|
|
carbon catabolite regulation of transcription from rna polymerase ii promoter
|
GO:0000429 |
4 |
0.027
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.027
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.027
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.027
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.026
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.026
|
|
|
|
positive regulation of protein sumoylation
|
GO:0033235 |
3 |
0.026
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.026
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.026
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.026
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.026
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.026
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.026
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.025
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.025
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.025
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.025
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.025
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.025
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.025
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.025
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.024
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.024
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.024
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.024
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.024
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway in response to dna damage
|
GO:1902231 |
6 |
0.024
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.024
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.024
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.024
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.023
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.023
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.023
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.023
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.023
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.023
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.022
|
|
|
|
regulation of transcription factor import into nucleus
|
GO:0042990 |
24 |
0.022
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.022
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.022
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.022
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.022
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.022
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.022
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.022
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.021
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.021
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.021
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.021
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.021
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.021
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.021
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.021
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.021
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.021
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.021
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.021
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.020
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.020
|
|
|
|
carbon catabolite regulation of transcription
|
GO:0045990 |
4 |
0.020
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.020
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.020
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.020
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.020
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.020
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.020
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.020
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.020
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.020
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.020
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.020
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.020
|
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.019
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.019
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.019
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.019
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.019
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.019
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.019
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.019
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.019
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.019
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.018
|
|
|
|
regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:2000058 |
14 |
0.018
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.018
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.018
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.018
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.018
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.018
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.018
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.018
|
|
|
|
regulation of keratinocyte apoptotic process
|
GO:1902172 |
1 |
0.018
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.018
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.018
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.018
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.018
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.018
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.018
|
|
|
|
spermatid nucleus differentiation
|
GO:0007289 |
19 |
0.018
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.018
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.018
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.018
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.017
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.017
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.017
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.017
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.017
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.017
|
|
|
|
histone h3 k9 dimethylation
|
GO:0036123 |
4 |
0.017
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.017
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.017
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.017
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.017
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.017
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.017
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.017
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter by galactose
|
GO:0000435 |
1 |
0.017
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.017
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.017
|
|
|
|
negative regulation of protein ubiquitination
|
GO:0031397 |
19 |
0.017
|
|
|
|
secretory granule organization
|
GO:0033363 |
20 |
0.017
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.017
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.017
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.017
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.017
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.017
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.016
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.016
|
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
38 |
0.016
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.016
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.016
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.016
|
|
|
|
negative regulation of inclusion body assembly
|
GO:0090084 |
1 |
0.016
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.016
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.016
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.016
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.016
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.016
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.016
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.016
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.016
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.016
|
|
|
|
protein sumoylation
|
GO:0016925 |
14 |
0.016
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.015
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.015
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.015
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.015
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.015
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.015
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.015
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.015
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.015
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.015
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.015
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.015
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.015
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
16 |
0.015
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.015
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.015
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.015
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.015
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.015
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.015
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.015
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.015
|
Mouse |
|
|
dna repair
|
GO:0006281 |
107 |
0.015
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.015
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.015
|
|
|
|
positive regulation of keratinocyte differentiation
|
GO:0045618 |
3 |
0.015
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.015
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.015
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.015
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.015
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.014
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.014
|
|
|
|
ventral spinal cord interneuron fate commitment
|
GO:0060579 |
14 |
0.014
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.014
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.014
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.014
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.014
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.014
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.014
|
|
|
|
regulation of transcription by galactose
|
GO:0000409 |
1 |
0.014
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.014
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.014
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.014
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.014
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.014
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.013
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.013
|
Mouse |
|
|
b cell activation
|
GO:0042113 |
161 |
0.013
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.013
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.013
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.013
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.013
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.013
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.013
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.013
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.013
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.013
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.013
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.013
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.013
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.013
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.013
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.013
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.013
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.013
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.013
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.013
|
|
|
|
schwann cell development
|
GO:0014044 |
22 |
0.013
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.013
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.013
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.013
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.013
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.013
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.013
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.013
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.013
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.013
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.013
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.013
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.013
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.012
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.012
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.012
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.012
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.012
|
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
36 |
0.012
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.012
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.012
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.012
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.012
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.012
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.012
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.012
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.012
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.012
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.012
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.012
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.012
|
|
|
|
inclusion body assembly
|
GO:0070841 |
3 |
0.012
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.012
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.012
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.012
|
|
|
|
maintenance of protein location in cell
|
GO:0032507 |
20 |
0.012
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.012
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.012
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.012
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.012
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.012
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.012
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.012
|
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.012
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.012
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.012
|
|
|
|
cellular response to topologically incorrect protein
|
GO:0035967 |
25 |
0.012
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.012
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.012
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.012
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.012
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.011
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.011
|
|
|
|
rab protein signal transduction
|
GO:0032482 |
1 |
0.011
|
|
|
|
negative regulation of cellular protein catabolic process
|
GO:1903363 |
22 |
0.011
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.011
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.011
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.011
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.011
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.011
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.011
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.011
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.011
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.011
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.011
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.011
|
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.011
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.011
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.011
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.011
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.011
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.011
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.011
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.011
|
|
|
|
negative regulation of intracellular protein transport
|
GO:0090317 |
27 |
0.011
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.011
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.011
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.011
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.011
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.011
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.011
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.011
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.011
|
|
|
|
microtubule cytoskeleton organization involved in mitosis
|
GO:1902850 |
4 |
0.011
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.011
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.011
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.011
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.011
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.011
|
|
|
|
chromosome condensation
|
GO:0030261 |
10 |
0.011
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.011
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.011
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.011
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.011
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.011
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.011
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.011
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.011
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.010
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.010
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.010
|
|
|
|
axon target recognition
|
GO:0007412 |
4 |
0.010
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.010
|
|
|
|
intra golgi vesicle mediated transport
|
GO:0006891 |
1 |
0.010
|
|
|
|
protein modification by small protein removal
|
GO:0070646 |
21 |
0.010
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.010
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.010
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.010
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.010
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.010
|
|
|
|
negative regulation of cytoplasmic transport
|
GO:1903650 |
29 |
0.010
|
|
|
|
response to uv
|
GO:0009411 |
44 |
0.010
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.010
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.010
|
|
|
|
misfolded protein transport
|
GO:0070843 |
1 |
0.010
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.010
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.010
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.010
|
|
